EUVIMEDEUVIMED entdecken
Crossref

Ketogenic Diet Therapy in Adolescents With Drug‐Resistant Epilepsy: An Insight From Efficacy, Mechanisms, and Clinical Applications

Hamid Noori, Ali Dheyaa Marsool, Mohammed Elmujtba Adam Essa, Krutika Mahendra Gohil, Alaa Mohammed Oudah, Abdullah Sultany, Humaira Sadat Sultany, Shafi Ullah Zahid, Saurav Kumar Mishra

Neurology and Clinical Neuroscience · 2026-11 · 14 (6) · 445-458

DOI: 10.1002/ncn3.70134 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurology and Clinical Neuroscience, online erschienen am 11.06.2026. Verfasst von Hamid Noori und 8 weiteren Autor:innen. Die Arbeit nennt 55 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epilepsy is a chronic neurological disorder marked by recurrent seizures and psychological consequences, affecting about 1% of the population. The etiology of epilepsy, according to the latest International League Against Epilepsy classification, includes structural, infectious, genetic, immune, metabolic, and unknown categories based on the underlying mechanisms. Standard treatments include anti‐seizure medications, surgery, and neuromodulation techniques such as vagus nerve stimulation and responsive neurostimulation, which reduce seizures but seldom provide a cure. Around one‐third of adolescents develop drug‐resistant epilepsy (DRE), which severely impairs mental health and quality of life, highlighting the need for alternative therapies. The ketogenic diet (KD), a high‐fat, low‐carbohydrate regimen, is a promising non‐pharmacological option. KD shifts metabolism from glucose to ketone bodies produced by the liver, stabilizing neuronal function, improving cognition, and reducing seizures. Clinical data show roughly 30% of DRE patients on KD achieve ≥ 50% seizure reduction, and some become seizure‐free. KD variants allow personalized treatment: the classic KD is most restrictive and effective for refractory cases; the medium‐chain triglyceride (MCT) diet is more flexible while boosting ketogenesis; the modified Atkins diet (MAD) is easier and popular with adolescents; and the low glycemic index treatment (LGIT) offers the fewest restrictions for lower‐risk patients. Despite its effectiveness, KD can pose social and nutritional challenges and carry potential side effects, so monitoring is essential. Nevertheless, KD remains a valuable, evidence‐based adjunct for managing DRE, can improve seizure control, and overall quality.

Zitieren

APA

Noori, H., Marsool, A. D., Essa, M. E. A., Gohil, K. M., Oudah, A. M., Sultany, A., Sultany, H. S., Zahid, S. U., & Mishra, S. K. (2026). Ketogenic Diet Therapy in Adolescents With Drug‐Resistant Epilepsy: An Insight From Efficacy, Mechanisms, and Clinical Applications. Neurology and Clinical Neuroscience, 14(6), 445-458. https://doi.org/10.1002/ncn3.70134

Vancouver

Noori H, Marsool AD, Essa MEA, Gohil KM, Oudah AM, Sultany A, et al. Ketogenic Diet Therapy in Adolescents With Drug‐Resistant Epilepsy: An Insight From Efficacy, Mechanisms, and Clinical Applications. Neurology and Clinical Neuroscience. 2026;14(6):445-458. doi:10.1002/ncn3.70134

BibTeX
@article{Noori2026,
  author = {Noori, Hamid and Marsool, Ali Dheyaa and Essa, Mohammed Elmujtba Adam and Gohil, Krutika Mahendra and Oudah, Alaa Mohammed and Sultany, Abdullah and Sultany, Humaira Sadat and Zahid, Shafi Ullah and Mishra, Saurav Kumar},
  title = {Ketogenic Diet Therapy in Adolescents With Drug‐Resistant Epilepsy: An Insight From Efficacy, Mechanisms, and Clinical Applications},
  journal = {Neurology and Clinical Neuroscience},
  year = {2026},
  volume = {14},
  number = {6},
  pages = {445--458},
  doi = {10.1002/ncn3.70134}
}
Kostenlos starten →